Facebook
Instagram
Twitter
Vimeo
Youtube
Sign in
Business
Markets
Entertainment
Sports
Technology
Nation
World
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Business Headline
The Name You Know. The News You Need.
Business
Markets
Entertainment
Sports
Technology
Nation
World
Home
Tags
Nasdaq:CMPS
Tag: Nasdaq:CMPS
Nasdaq
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire
-
April 2, 2024
0
Nasdaq
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
GlobeNewswire
-
March 28, 2024
0
Nasdaq
Compass Pathways to participate in upcoming TD Cowen investor conference
GlobeNewswire
-
February 27, 2024
0
Nasdaq
Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
GlobeNewswire
-
February 23, 2024
0
Market
Compass Pathways to participate in upcoming Oppenheimer investor conference
GlobeNewswire
-
February 1, 2024
0
Nasdaq
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
GlobeNewswire
-
January 16, 2024
0
Market
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
GlobeNewswire
-
January 5, 2024
0
Nasdaq
Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder
GlobeNewswire
-
December 20, 2023
0
Market
Compass Pathways appoints Teri Loxam as Chief Financial Officer
GlobeNewswire
-
December 7, 2023
0
Nasdaq
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
GlobeNewswire
-
December 7, 2023
0
1
2
3
Page 1 of 3
error: